WT1 Immunoreactivity in Uterine Papillary Serous Carcinomas Is Different From Ovarian Serous Carcinomas
Open Access
- 1 April 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 117 (4) , 541-545
- https://doi.org/10.1309/k84k-005f-tcb8-fv4b
Abstract
WT1 diffusely stains most ovarian serous carcinomas; reactivity of uterine papillary serous carcinomas has not been evaluated. We studied WT1 expressKeywords
This publication has 15 references indexed in Scilit:
- Hysteroscopic and Immunohistochemical Findings in Type I and Type II Endometrial CarcinomasThe Journal of the American Association of Gynecologic Laparoscopists, 2001
- Endometrial Intraepithelial Carcinoma With Associated Peritoneal CarcinomatosisThe American Journal of Surgical Pathology, 2000
- Value of Thyroid Transcription Factor-1, E-Cadherin, BG8, WT1, and CD44S Immunostaining in Distinguishing Epithelial Pleural Mesothelioma From Pulmonary and Nonpulmonary AdenocarcinomaThe American Journal of Surgical Pathology, 2000
- The frequency of p53, k-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinomaCancer, 2000
- p53 Immunostaining as a Significant Adjunct Diagnostic Method for Uterine Surface CarcinomaThe American Journal of Surgical Pathology, 1998
- Comparative Analysis of Histologic Homologues of Endometrial and Ovarian CarcinomaThe American Journal of Surgical Pathology, 1998
- Functional properties ofWT1Medical and Pediatric Oncology, 1996
- Neoadjuvant Chemotherapy in Uterine Papillary Serous CarcinomaGynecologic Oncology, 1996
- Alternative splicing and genomic structure of the Wilms tumor gene WT1.Proceedings of the National Academy of Sciences, 1991
- Expression of the Wilms' tumor gene WT1 in the murine urogenital system.Genes & Development, 1991